Loading clinical trials...
Loading clinical trials...
A Randomised, Double-Blind, Placebo-Controlled, Dose-Response Study of the Efficacy and Safety of MEDI7352 in Subjects With Painful Diabetic Neuropathy
Conditions
Interventions
MEDI7352
Placebo
Locations
31
Denmark
Research Site
Gentofte Municipality, Denmark
Research Site
Balatonfüred, Hungary
Research Site
Budapest, Hungary
Research Site
Bydgoszcz, Poland
Research Site
Gdansk, Poland
Research Site
Katowice, Poland
Start Date
November 19, 2018
Primary Completion Date
June 29, 2023
Completion Date
June 29, 2023
Last Updated
September 19, 2024
NCT06524284
NCT04055090
NCT04857957
NCT05620225
NCT06383702
NCT05993871
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions